investor sppirx.com

Spectrum Pharmaceuticals, Inc. - Investor Relations

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

OVERVIEW

This web page investor.sppirx.com currently has a traffic classification of zero (the lower the superior). We have scanned twenty pages inside the site investor.sppirx.com and found eight websites referring to investor.sppirx.com. We were able to observe one public web accounts owned by this website.
Pages Crawled
20
Links to this site
8
Social Links
1

INVESTOR.SPPIRX.COM RANKINGS

This web page investor.sppirx.com has seen variant levels of traffic all round the year.
Traffic for investor.sppirx.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for investor.sppirx.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for investor.sppirx.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO WEB SITE

WHAT DOES INVESTOR.SPPIRX.COM LOOK LIKE?

Desktop Screenshot of investor.sppirx.com Mobile Screenshot of investor.sppirx.com Tablet Screenshot of investor.sppirx.com

INVESTOR.SPPIRX.COM HOST

Our parsers discovered that a lone root page on investor.sppirx.com took four hundred and eighty-one milliseconds to come up. I could not detect a SSL certificate, so therefore we consider investor.sppirx.com not secure.
Load time
0.481 secs
SSL
NOT SECURE
Internet Protocol
206.200.251.19

BROWSER ICON

PAGE TITLE

Spectrum Pharmaceuticals, Inc. - Investor Relations

DESCRIPTION

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

CONTENT

This web page investor.sppirx.com states the following, "Spectrum Pharmaceuticals stock is traded through the Nasdaq Global Market System." We saw that the website stated " Spectrum Pharmaceuticals Reports Second Quarter 2015 Financial Results and Pipeline Update." It also said " Spectrum Pharmaceuticals Announces Second Quarter 2015 Financial Results Teleconference and Webcast. 400 PM ET on Aug 14, 2015. Delayed at least 20 minutes. Annual report and proxy information." The header had spectrum pharmaceuticals as the highest ranking optimized keyword. It is followed by zevalin, fusilev, and oncology which isn't as ranked as highly as spectrum pharmaceuticals. The next words investor.sppirx.com used was FDA-marketed. oncology drugs was included but will not be seen by search engines.

SEEK SIMILAR WEBSITES

Verso Corporation - Investor Relations

Headquartered in Memphis, Tennessee, with a business center in Miamisburg, Ohio, Verso operates eight mills strategically located in Kentucky, Maine, Maryland, Michigan, Minnesota and Wisconsin with a total annual production capacity of approximately 3. Second Quarter 2015 Earnings Conference Call.

Zimmer Biomet -- Investor Relations

Zimmer Biomet - Delivering Value. Founded in 1927 and headquartered in Warsaw, Indiana, USA, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Recent News Releases and Information. Zimmer Completes Combination with Biomet.

ResMed - Investor relations

Last twelve month annual sales. Adjusted EPS growth over the last five years. Free cash flow returned to shareholders over the last five years. Announces Results for the Fourth Quarter and Fiscal Year 2015. ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical.

SanDisk IT Blog Insight on Data Center Cloud Innovation

Sign In or Create An Account. August 12, 2015 by Nithya Ruff.